NR2F6, a new immune checkpoint that acts as a potential biomarker of immunosuppression and contributes to poor clinical outcome in human glioma
Article in Frontiers in Immunology (July 2023)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Uncovering the Immune Cell Infiltration Landscape in Low-Grade Glioma for Aiding Immunotherapy
Article in Journal of Oncology (March 2022)
Construction of an immune infiltration-associated ceRNA network and prognostic model for low-grade gliomas
Preprint in Research Square (February 2022)